Research on Promising New Treatments
While chemotherapy can halt the progression of AL amyloidosis, it cannot reverse the damage caused by the disease. Our researchers are studying new monoclonal antibodies that could remove amyloid deposits and improve the function of your heart, kidney, lungs, and other organ systems. As a Duke patient, you may have access to our ongoing clinical trials, which study new therapeutic approaches that are not widely available or accessible at most other hospitals.
A Team of Experts
Our team of amyloidosis experts -- including hematologist/oncologists, cardiologists, kidney specialists, gastroenterologists, neurologists, and others --meets regularly to share information on patient care, new therapies, and more. Receiving your care from a team of experienced specialists ensures you receive the best-possible outcome.